Does the HPV Vaccine Protect Against Premature Birth? A New Study Suggests It Might

A pregnant patient is examined by a health care provider

We already know that the HPV vaccine helps prevent genital warts, cervical cancer, cancers of the penis, vulva and vagina, and cancers of the neck and throat caused by human papillomavirus (HPV). Now, a new study suggests it may have another benefit: lowering the chance of certain pregnancy complications.

A new study published in The BMJ found that people who had received the HPV vaccine before pregnancy were less likely to give birth early than those who were unvaccinated.

What did the study find?

Researchers looked at 624,713 births in Sweden between 2006 and 2023 and compared pregnancy outcomes in patients who had received the HPV vaccine with those in patients who had not. The clearest finding involved babies born too early.

A full-term pregnancy lasts about 40 weeks. Babies born before 37 weeks are considered premature, and those born even earlier than that can face more serious health problems.

The results show that people who had gotten the HPV vaccine had:

  • 5% lower odds of giving birth prematurely (before 37 weeks) than unvaccinated people
  • 15% lower odds of giving birth very prematurely (between 28 and 31 weeks) than unvaccinated people
  • 5% lower odds of experiencing spontaneous preterm birth (meaning labor started on its own rather than being started by a medical procedure) than unvaccinated people

The researchers also found that the age at which someone received the vaccine seemed to matter. People vaccinated before age 17 were 10% less likely to have a preterm birth and 11% less likely to have a spontaneous preterm birth compared with those who weren’t vaccinated.

Today’s HPV vaccine protects against nine types of HPV, including those responsible for most HPV-related cancers and genital warts. The people in this study received an older vaccine that protected against four types.

Most HPV infections go away on their own. But some last longer and can cause health problems. HPV causes nearly all cases of cervical cancer. It can also cause cancers of the vulva, vagina, penis, anus, and back of the throat.

How does HPV affect pregnancy?

Researchers are still learning how HPV may affect pregnancy. Studies have found a few possible connections.

First, some studies suggest that HPV may affect the development of the placenta, the organ that provides oxygen and nutrients to a developing fetus.
Second, certain types of HPV can cause abnormal cells to develop on the cervix. Sometimes these cells need to be removed to be tested or to prevent cervical cancer. Other studies have linked a history of these procedures to complications in future pregnancies.

Still, researchers don’t yet know exactly why vaccinated people in this study had fewer pregnancy complications, and the study doesn’t prove that the HPV vaccine prevents premature birth. There may have been other reasons why the vaccinated group had fewer complications.

Should you get vaccinated?

The HPV vaccine is routinely recommended for people ages 11 to 26, but it can be given as young as 9 or as old as 45. The vaccine works best before someone is exposed to HPV, but people who are already sexually active can still benefit. If you weren’t vaccinated as a tween or teen, ask your health care provider about catch-up vaccines.

The HPV vaccine isn’t recommended during pregnancy.

We already have excellent reasons to get the HPV vaccine: It prevents cancer. This new research suggests it might also help contribute to healthy pregnancies. More research is needed, but the findings give us another reason to be enthusiastic about HPV prevention.

More on HPV

HPV screening with self collection endorsed by two organizations

HPV Screening with Self Collection Endorsed by Three Organizations

Three organizations—ACS, ACOG, and HRSA—have each recently endorsed new guidelines for cervical cancer screening. All of them discuss screening with self collected samples.
An adolescent gives a thumbs up after getting an HPV vaccine

Is One Shot of the HPV Vaccine Enough?

Research suggests that only one dose of the HPV vaccine may be effective enough to prevent HPV-related disease, including cancer.
Australia

Australia is Closer to Ending Cervical Cancer

Australia has been a leader in cervical cancer prevention for decades and is now close to eliminating the disease.
A stethoscope and a teal ribbon

ACS Releases New Cervical Cancer Screening Guidelines

The American Cancer Society (ACS) released new recommendations for cervical cancer screening that focus on HPV testing and approve the use of self-collected samples. The recommendations also clarify the age at which screening should start and stop.
A visual representation of herd immunity

Study Shows Herd Immunity for HPV is Possible

We’ve known for years that the HPV vaccine works. Now new research shows that widespread vaccination even protects those who haven’t gotten the shot. This study proves that it is possible to reach herd immunity for HPV.
A woman holds a Teal Wand, a device for at-home cervical cancer screening

FDA Approves At-Home Collection Device for Cervical Cancer Screening 

The FDA just approved the Teal Wand, a self-collection device for HPV testing that does not require a speculum exam or even a trip to the doctor’s office. People can collect their own sample at home and send it to a lab for analysis.